Blood Coagulation Articles & Analysis
11 news found
About FXIa inhibitors and Asundexian Factor XI is a protein in the blood which is converted into its active enzyme form (Factor XIa) as part of the blood coagulation cascade. ...
ByBayer AG
What is a CO2 laser The CO2 laser, which has been used as a medical laser for decades, works by absorbing the energy of the laser and heating the water in the tissue into water vapour, resulting in vaporisation and exfoliation, with the remaining heat producing coagulation, closure of blood vessels and stimulation of type I and type III collagen renewal. ...
Amerigo Scientific, a distributor focused on providing critical products and services to the biomedical and life science communities, recently announced the launch of its new polyclonal antibody to human blood coagulation factor XIII to support researchers in life science fields for the detection of blood coagulation factor XIII. ...
Entegrion Announces CE Mark for Point of Care System for Blood Coagulation Monitoring. Regulatory clearance makes Entegrion’s innovative point of care diagnostic instrument for viscoelastic coagulation testing available to clinicians in Europe. ...
Factor XI is a protein in the blood which is converted into its active enzyme form (Factor XIa) as part of the blood coagulation cascade. ...
ByBayer AG
--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and blood-based assays as companion diagnostics for RETEVMO® and other therapies in Loxo Oncology at Lilly’s pipeline. ...
The ILEX Group is closely affiliated with leading multinational medical conglomerates, like Abbott, Hologic, Grifols, BioMerieux, IL Sebia, and Fertilitech, and provides a forefront of solutions in medical fields such as microbiology, blood banking, Hematology coagulation, I.V.F and more. ILEX Medical serves major clients including the Israeli Ministry of Health, ...
Under the new agreements, TRICARE beneficiaries now have improved access to Foundation Medicine’s FDA-approved comprehensive genomic profiling (CGP) tests, FoundationOne®CDx and FoundationOne®Liquid CDx, in accordance with their approved indications for all solid tumors. Through tissue or blood samples, FoundationOne CDx and FoundationOne Liquid CDx evaluate more ...
The platform utilizes proprietary technology for fast and highly accurate measurement of blood viscoelasticity and density, characterizing the entire blood coagulation cascade from blood clot formation to lysis, enabling the detection of blood clotting or bleeding disorders and guiding the use of therapy for ...
The platform utilizes proprietary technology for fast and highly accurate measurement of blood viscoelasticity and density, characterizing the entire blood coagulation cascade from blood clot formation to lysis, enabling the detection of blood clotting or bleeding disorders and guiding the use of therapy for ...
(NYSE: A) today introduced the new SureDirect Blood PCR Kit for amplification of DNA directly from blood and blood derivatives, without the need for nucleic acid extraction and isolation. This kit simplifies the DNA amplification workflow and decreases turn-around time by enabling PCR (polymerase chain reaction) directly from fresh, frozen and ...